Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A, McGhee N, Tomassini JE, Chen X, Ying Chang, Sutherland A, Montefiori DC, Girard B, Edwards DK, Jing Feng, Zhou H, Baden LR, Miller JM, Das R.
Chalkias S, et al. Among authors: tomassini je.
Nat Commun. 2023 Aug 23;14(1):5125. doi: 10.1038/s41467-023-38892-w.
Nat Commun. 2023.
PMID: 37612300
Free PMC article.